$1.14/ day, billed weekly
Cancel anytime

(Ad-Free, Unlimited access)

NO CREDIT CARD REQUIRED

PHSE

Pharmhouse Corp (PHSE)

$0.05

Last Close (24-hour delay)

PASS

BUY Advisory
SELL Advisory (Profit)
SELL Advisory (Loss)

Profit
Loss
Pass (Skip investing)

Time period over

ALL
YEAR
MONTH
WEEK

Upturn Advisory Summary

06/30/2025: PHSE (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

Analysts Price Target For last 52 week

$0Target price

Low$

Current$0.05

high$

Trends

0	Strong Buy
0	Buy
0	Hold
0	Sell
0	Strong Sell

Analysis of Past Performance

Type Stock

Historic Profit -100%

Avg. Invested days 43

Today’s Advisory PASS

Upturn Star Rating

Upturn Advisory Performance

1.0

Stock Returns Performance

1.0

Profits based on simulation

Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock	Market Capitalization 41.65M USD	Price to earnings Ratio -	1Y Target Price -
Price to earnings Ratio -	1Y Target Price -
Volume (30-day avg) -	Beta 1.6	52 Weeks Range 0.00 - 0.06	Updated Date 06/28/2025
52 Weeks Range 0.00 - 0.06	Updated Date 06/28/2025
Dividends yield (FY) -	Basic EPS (TTM) -

Earnings Date

Report Date -

When -

Estimate -

Actual -

Profitability

Profit Margin -35.31%

Operating Margin (TTM) 19.63%

Management Effectiveness

Return on Assets (TTM) -6.44%

Return on Equity (TTM) -56.66%

Valuation

Trailing PE -	Forward PE -	Enterprise Value 42581926	Price to Sales(TTM) 3315.17
Enterprise Value 42581926	Price to Sales(TTM) 3315.17
Enterprise Value to Revenue -	Enterprise Value to EBITDA -	Shares Outstanding 851638976	Shares Floating -
Shares Outstanding 851638976	Shares Floating -
Percent Insiders -	Percent Institutions -

Analyst Ratings

Rating -	Target Price -	Buy -	Strong Buy -
Buy -	Strong Buy -
Hold -	Sell -	Strong Sell -
Strong Sell -

About Pharmhouse Corp

Exchange NASDAQ	Headquaters Warden, WA, United States
IPO Launch date -	CEO & Director Mr. Ronald M. Herzfeld
Sector Communication Services	Industry Entertainment	Full time employees 2	Website
Full time employees 2	Website

Parliament House Enterprises, Inc. produces and sells cannabidiol (CBD) and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Hempstract, Inc. and changed its name to Parliament House Enterprises, Inc. in May 2025. Parliament House Enterprises, Inc. is based in Warden, Washington.

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.